Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Celeghini

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Journal of Leukocyte Biology|June 4, 2008
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL)Federica Corallini, Claudio Celeghini
Current Pharmaceutical Design|March 12, 2011
Recent advances in the therapeutic perspectives of Nutlin-3Paola Secchiero, Raffaella Bosco, Claudio Celeghini, et al.
Current Medicinal Chemistry|September 14, 2017
Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into PracticeAnnalisa Marcuzzi, Claudia Loganes, Claudio Celeghini, et al.
Cellular and Molecular Life Sciences : CMLS|January 15, 2014
NF-κB pathways in hematological malignanciesChiara Gasparini, Claudio Celeghini, Lorenzo Monasta, et al.
Atherosclerosis|March 28, 2007
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitusClaudio Celeghini, Roberta Bortul, Roberto Fadda, et al.
Mediators of Inflammation|June 27, 2014
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometryCarlo Cervellati, Paola Secchiero, Gloria Bonaccorsi, et al.
Experimental and Therapeutic Medicine|November 6, 2014
Levels of circulating TNF-related apoptosis-inducing ligand in celiac diseaseClaudio Celeghini, Tarcisio Not, Alessia Norcio, et al.
British Journal of Haematology|December 5, 2009
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activityRebecca Voltan, Claudio Celeghini, Elisabetta Melloni, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 15, 2012
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cellsElisabetta Melloni, Giorgio Zauli, Claudio Celeghini, et al.
Investigational New Drugs|February 5, 2010
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell linesClaudio Celeghini, Rebecca Voltan, Erika Rimondi, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Journal of Leukocyte Biology|June 4, 2008
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL)Federica Corallini, Claudio Celeghini
Current Pharmaceutical Design|March 12, 2011
Recent advances in the therapeutic perspectives of Nutlin-3Paola Secchiero, Raffaella Bosco, Claudio Celeghini, et al.
Current Medicinal Chemistry|September 14, 2017
Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into PracticeAnnalisa Marcuzzi, Claudia Loganes, Claudio Celeghini, et al.
Cellular and Molecular Life Sciences : CMLS|January 15, 2014
NF-κB pathways in hematological malignanciesChiara Gasparini, Claudio Celeghini, Lorenzo Monasta, et al.
Atherosclerosis|March 28, 2007
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitusClaudio Celeghini, Roberta Bortul, Roberto Fadda, et al.
Mediators of Inflammation|June 27, 2014
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometryCarlo Cervellati, Paola Secchiero, Gloria Bonaccorsi, et al.
Experimental and Therapeutic Medicine|November 6, 2014
Levels of circulating TNF-related apoptosis-inducing ligand in celiac diseaseClaudio Celeghini, Tarcisio Not, Alessia Norcio, et al.
British Journal of Haematology|December 5, 2009
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activityRebecca Voltan, Claudio Celeghini, Elisabetta Melloni, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 15, 2012
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cellsElisabetta Melloni, Giorgio Zauli, Claudio Celeghini, et al.
Investigational New Drugs|February 5, 2010
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell linesClaudio Celeghini, Rebecca Voltan, Erika Rimondi, et al.
Pageof 6